The all-in-one solution includes a virtual consultation, clinically proven prescription medication, and discreet home delivery, starting as low as $16/month SANTA MONICA, Calif. / Oct 15, 2025 / Business Wire / GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the launch of a new subscription for hair loss treatment . Built for simplicity and transparency, GoodRx for Hair Loss... Read More

SANTA MONICA, Calif. / Oct 08, 2025 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for medication savings in the U.S., today announced it will release its third quarter 2025 financial results after U.S. markets close on Tuesday, November 4, 2025. GoodRx management will also hold a conference call and webcast the following morning, Wednesday, November 5, 2025 at 5:00... Read More

The collaboration with Amgen reduces out-of-pocket costs for patients and expands access to an innovative cholesterol-lowering therapy SANTA MONICA, Calif. / Oct 06, 2025 / Business Wire / GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the availability of Repatha® (evolocumab), a cholesterol-lowering therapy, at a significantly reduced cash price. Starting today, patients can... Read More

RxSmartSaver powered by GoodRx delivers instant affordability at the pharmacy counter, giving consumers easier access to savings on widely used brand-name medications SANTA MONICA, Calif. / Oct 01, 2025 / Business Wire / GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the availability of its brand medication savings solution, RxSmartSaver powered by GoodRx, at Kroger pharmacies... Read More

Developed in-house, the campaign flips the script on traditional healthcare advertising in a culturally relevant, full-funnel campaign SANTA MONICA, Calif. / Sep 02, 2025 / Business Wire / GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., is riding into new creative territory with the launch of The Savings Wrangler , a groundbreaking brand campaign that aims to bring the company’s mission to... Read More

Until today, Ozempic ® has not been available to eligible self-paying patients at this price SANTA MONICA, Calif. / Aug 18, 2025 / Business Wire / GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced that via a collaboration with Novo Nordisk , all strengths of Ozempic ® (semaglutide) and Wegovy ® (semaglutide) pens are available to eligible self-paying patients for $499-per-month... Read More

Second Quarter 2025 Revenue and Adjusted EBITDA Margin in Line with Previous Guidance; Pharma Manufacturer Solutions Revenue Increased 32% Year-Over-Year SANTA MONICA, Calif. / Aug 06, 2025 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” or the “Company”), the leading platform for medication savings in the U.S., has released its financial results for the second quarter of 2025. Second... Read More

Seasoned industry leader tapped to help pharma reimagine their go-to-market strategies and direct-to-patient models SANTA MONICA, Calif. / Jul 28, 2025 / Business Wire / GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the appointment of Laura Jensen as Chief Commercial Officer and President of Pharma Solutions, effective July 28, 2025. In this role, Laura will lead the... Read More

SANTA MONICA, Calif. / Jul 09, 2025 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for medication savings in the U.S., today announced it will release its second quarter 2025 financial results after U.S. markets close on Wednesday, August 6, 2025. GoodRx management will also hold a conference call and webcast the following morning, Thursday, August 7, 2025 at 5:00... Read More

The all-in-one solution includes virtual consultation, FDA-approved prescription medication, and discreet home delivery, with no hidden fees, in-person visits, or memberships required SANTA MONICA, Calif. / Jun 10, 2025 / Business Wire / GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the launch of a new subscription service for erectile dysfunction (ED). Designed to meet... Read More

Community Link allows independent pharmacies to direct contract with GoodRx, manage participation in the company’s Integrated Savings Program, and access over 90 brand medication partnership offerings Cost-plus pricing is anchored on NADAC Starting July 1, all independent pharmacies will be opted out of GoodRx’s Integrated Savings Program by default SANTA MONICA, Calif. / Jun 09, 2025 / Business Wire / GoodRx (Nasdaq: GDRX),... Read More

Public release of Lifecycle reflects company’s commitment to transparency, innovation, and community collaboration SANTA MONICA, Calif. / Jun 05, 2025 / Business Wire / GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced it is open-sourcing Lifecycle, a homegrown development tool designed to improve team velocity, streamline review workflows, and reduce infrastructure overhead.... Read More

GoodRx is hosting a webinar on June 3 and 4 to discuss how the company is supporting direct contracting with GoodRx SANTA MONICA, Calif. / May 22, 2025 / Business Wire / GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced that it will launch a new offering for independent community pharmacies - GoodRx Community Link - in June 2025. GoodRx Community Link will enable locally owned... Read More

First Quarter 2025 Revenue In-line; Adjusted EBITDA Margin Beats Previous Guidance; Maintains Full Year 2025 Revenue Guidance Range; Raises Adjusted EBITDA Expectations SANTA MONICA, Calif. / May 07, 2025 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” or the “Company”), the leading platform for medication savings in the U.S., has released its financial results for the first quarter of... Read More

SANTA MONICA, Calif. / Apr 09, 2025 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for medication savings in the U.S., today announced it will release its first quarter 2025 financial results after U.S. markets close on Wednesday, May 7, 2025. GoodRx management will also hold a conference call and webcast the following morning, Thursday, May 8, 2025 at 5:00 a.m.... Read More

Company working with Hy-Vee as launch partner to simplify how consumers get their medications through the GoodRx platform SANTA MONICA, Calif. / Apr 03, 2025 / Business Wire / GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced a new e-commerce experience for retail pharmacies that improves how consumers get their medications via the GoodRx platform. The company is launching the... Read More

Accomplished healthcare executives will work to drive growth, strengthen industry partnerships, and enhance pharmacy innovation at GoodRx SANTA MONICA, Calif. / Mar 17, 2025 / Business Wire / GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the appointment of Aaron Crittenden as President of Rx Marketplace and Scott Pope, PharmD, as Chief Pharmacy Officer and Head of Clinical... Read More

Women Spent $8.8 Billion More than Men in 2024, with Women Ages 18-44 Facing the Steepest Out-of-Pocket Cost Disparity SANTA MONICA, Calif. / Mar 10, 2025 / Business Wire / GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today released a new report, The Prescription Drug Gender Divide , detailing how women shoulder a significantly greater out-of-pocket cost burden than men. The data shows that... Read More

Fourth Quarter and Full Year 2024 Results Substantially In-line with Previous Guidance SANTA MONICA, Calif. / Feb 27, 2025 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” or the “Company”), the leading prescription savings platform in the U.S., has released its financial results for the fourth quarter and full year of 2024. Fourth Quarter 2024 Highlights Revenue 1 of $198.6 million Net... Read More

HITRUST certification validates that GoodRx is operating leading security practices to protect sensitive information SANTA MONICA, Calif. / Feb 18, 2025 / Business Wire / GoodRx (Nasdaq: GDRX), the leading medication savings platform in the U.S., today announced its drug savings platform residing with Amazon Web Services (AWS) has earned certified status for 2025 by HITRUST for information security. This milestone... Read More

Seasoned industry executive brings decades of financial strategy and leadership experience to GoodRx SANTA MONICA, Calif. / Feb 05, 2025 / Business Wire / GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today announced that Christopher A. McGinnis has been appointed as Chief Financial Officer, effective February 4, 2025. Chris brings 30 years of extensive financial experience across the... Read More

SANTA MONICA, Calif. / Jan 30, 2025 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced it will release its fourth quarter and full year 2024 financial results before U.S. markets open on Thursday, February 27, 2025. GoodRx management will also hold a conference call and webcast that morning at 5:00 a.m. Pacific Time (8:00... Read More

Former GoodRx Interim CEO brings a deep understanding of the GoodRx business and extensive leadership experience to his role as Co-Chair of the Board SANTA MONICA, Calif. / Jan 22, 2025 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced that Scott Wagner has joined its Board of Directors, effective... Read More

Santa Monica-based GoodRx is helping its community by offering residents free online healthcare provider visits to refill lost medications or receive treatment for a variety of conditions SANTA MONICA, Calif. / Jan 10, 2025 / Business Wire / GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today announced it is offering free online healthcare provider visits to California residents impacted by... Read More

SANTA MONICA, Calif. / Dec 18, 2024 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced that executives from the Company will participate in a fireside chat at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 15, 2025 at 9:45 a.m. Pacific Time (12:45 p.m. Eastern Time). A live... Read More

50 Million Americans Face Critical Gaps in Care as Demand for Endocrinologists Surges Living in an Endocrinology Desert Increases Mortality Risk by 12%, Study Finds SANTA MONICA, Calif. / Dec 17, 2024 / Business Wire / GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today revealed startling healthcare disparities in its new report, “ Endocrinologist Deserts: A Critical Healthcare Gap for... Read More

Wendy Barnes, Current CEO of RxBenefits, Brings Extensive Healthcare Management Experience to the Company SANTA MONICA, Calif. / Dec 16, 2024 / Business Wire / GoodRx Holdings, Inc. (NASDAQ: GDRX), the leading prescription savings platform in the U.S., today announced that Wendy Barnes has been appointed as President and Chief... Read More

In 2024, fills for Wegovy and Zepbound increased by over 100% and 300%, respectively SANTA MONICA, Calif. / Dec 05, 2024 / Business Wire / GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today released a new Weight Loss Medications Tracker that provides an inside look at fill trends and spending patterns for weight loss medications across the U.S. The company found that limited insurance... Read More

SANTA MONICA, Calif. / Nov 07, 2024 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” or the “Company”), the leading prescription savings platform in the U.S., has released its financial results for the third quarter of 2024. Third Quarter 2024 Highlights Revenue 1 and Adjusted Revenue 1 of $195.3 million Net income of $4.0 million; Net income margin of 2.0% Adjusted Net Income 1 of $31.9... Read More

SANTA MONICA, Calif. / Nov 04, 2024 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced that executives from the Company will participate in a fireside chat at each of the following investor conferences: UBS 2024 Global Healthcare Conference in Rancho Palos Verdes, CA, on Tuesday, November 12, 2024 at 2 p.m. Eastern Time... Read More

First over-the-counter daily birth control pill now available to order via GoodRx’s new direct-to-consumer shopping experience SANTA MONICA, Calif. / Oct 31, 2024 / Business Wire / Today, GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., announced the rollout of its new e-commerce solution, with... Read More

First weight loss medication with an exclusive low cash price available on the GoodRx platform SANTA MONICA, Calif. / Oct 29, 2024 / Business Wire / GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., announced today that QSYMIA® (phentermine and topiramate extended-release capsules CIV) is available for a low cash price in more than 70,000 retail pharmacy locations nationwide exclusively via... Read More

IQVIA CFO brings 39 years of healthcare and finance expertise to GoodRx SANTA MONICA, Calif. / Oct 28, 2024 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced the election of Ronald E. Bruehlman to its Board of Directors, effective November 8, 2024. Mr. Bruehlman brings to GoodRx 39 years of finance... Read More

New GoodRx research shows menopause medications have increased in price by over 50% over the last decade SANTA MONICA, Calif. / Oct 23, 2024 / Business Wire / Today, GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., announced the availability of new affordability programs for menopause hormone... Read More

Approved users will now be able to select an Affirm payment plan for select medications directly on the GoodRx platform SAN FRANCISCO / Oct 16, 2024 / Business Wire / GoodRx (NASDAQ: GDRX), the leading prescription savings platform in the U.S., today announced consumers will soon be able to use Affirm to pay over time for select medications at participating retail pharmacies. This adds a convenient way for consumers to pay... Read More

SANTA MONICA, Calif. / Oct 10, 2024 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced it will release its third quarter 2024 financial results before U.S. markets open on Thursday, November 7, 2024. GoodRx management will also hold a conference call and webcast that morning at 5:00 a.m. Pacific Time (8:00 a.m. Eastern... Read More

neffy is available in pharmacies this week and the lowest discounted cash price at retail pharmacies can be found exclusively at GoodRx neffy is the first and only needle-free treatment for Type I allergic reactions, including anaphylaxis for adults and children who weigh ≥30 kg (66 lbs.) SANTA MONICA, Calif. / Sep 26, 2024 / Business Wire / GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today... Read More

SANTA MONICA, Calif. / Aug 21, 2024 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced that executives from the Company will participate in a fireside chat at each of the following investor conferences: Morgan Stanley 22nd Annual Global Healthcare Conference in New York, NY on Thursday, September 5, 2024 at 7:45 a.m.... Read More

SANTA MONICA, Calif. / Aug 08, 2024 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” or the “Company”), the leading prescription savings platform in the U.S., has released its financial results for the second quarter of 2024. Second Quarter 2024 Highlights Revenue 1 and Adjusted Revenue 1 of $200.6 million Net income of $6.7 million; Net income margin of 3.3% Adjusted Net Income 1 of $32.4... Read More

First biosimilar with an exclusive low cash price on the GoodRx platform RIDGEFIELD, Conn. and SANTA MONICA, Calif. , July 18, 2024 /PRNewswire/ -- Boehringer Ingelheim and GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., announced today a patient affordability initiative to provide citrate-free Adalimumab-adbm, Boehringer's biosimilar to Humira ® (adalimumab), at a low cash price available... Read More

SANTA MONICA, Calif. / Jul 11, 2024 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced it will release its second quarter 2024 financial results before U.S. markets open on Thursday, August 8, 2024. GoodRx management will also hold a conference call and webcast that morning at 5:00 a.m. Pacific Time (8:00 a.m. Eastern... Read More

Former Genentech CEO brings over 35 years of pharmaceutical and healthcare expertise to GoodRx SANTA MONICA, Calif. / Jul 10, 2024 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced the election of Ian T. Clark to its Board of Directors. Mr. Clark brings to GoodRx over 35 years of experience in the... Read More

Consumers have paid $21 billion out-of-pocket on prescription medications in 2024, an average of $16.26 per prescription SANTA MONICA, Calif. / Jun 26, 2024 / Business Wire / Today, GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., debuted its new Prescription Cost Tracker where it will monitor out-of-pocket prescription spending trends in the U.S. to help Americans better understand prescription... Read More

Former Dell Technologies and Skype Board member brings decades of tech, strategy and management experience to GoodRx SANTA MONICA, Calif. / May 30, 2024 / Business Wire / GoodRx (Nasdaq: GDRX), the leading destination for prescription savings in the U.S., today announced the election of Simon Patterson to its Board of Directors. Currently leading EMEA operations for the technology investment firm Silver Lake, Mr. Patterson... Read More

GoodRx honored for creating new ways to deliver significant savings on prescription medications SANTA MONICA, Calif. / May 30, 2024 / Business Wire / Today, GoodRx (Nasdaq: GDRX), the leading destination for prescription savings in the U.S., was named to the fourth-annual TIME100 Most Influential Companies list , which highlights companies making an extraordinary impact around the world. This is the second time GoodRx has... Read More

In 2023, Americans saved over $6 million on fertility medications using GoodRx SANTA MONICA, Calif. / May 22, 2024 / Business Wire / GoodRx , the leading destination for prescription savings in the U.S., today announced it is offering discounts of up to 43% on fertility treatments based on the best available GoodRx price, 1 including savings on generic and brand-name medications used during every phase of the in vitro... Read More

Companies now offering almost 50% more savings on most generics at more than 2,200 Kroger Family of Pharmacies SANTA MONICA, Calif. / May 15, 2024 / Business Wire / GoodRx (Nasdaq: GDRX), the leading destination for prescription savings in the U.S., today announced a new direct contracting agreement with The Kroger Co. to deliver improved prescription pricing at more than 2,200 Kroger family pharmacy locations nationwide.... Read More

SANTA MONICA, Calif. / May 09, 2024 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” or the “Company”), the leading destination for prescription savings in the U.S., has released its financial results for the first quarter of 2024. First Quarter 2024 Highlights Revenue 1 and Adjusted Revenue 1 of $197.9 million Net loss of $1.0 million; Net loss margin of 0.5% Adjusted Net Income 1 of... Read More

SANTA MONICA, Calif. / Apr 24, 2024 / Business Wire / GoodRx Holdings, Inc. ( Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings in the U.S., today announced it will hold its first Investor Day on May 15, 2024, in New York City. The event will begin at 9:00 a.m. Eastern Time (6:00 a.m. Pacific Time). The event will feature presentations by GoodRx’s Interim CEO, Scott Wagner; CFO,... Read More

SANTA MONICA, Calif. / Apr 11, 2024 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings in the U.S., today announced it will release its first quarter 2024 financial results before U.S. markets open on Thursday, May 9, 2024. GoodRx management will also hold a conference call and webcast that morning at 5:00 a.m. Pacific Time (8:00 a.m. Eastern... Read More

Company Announces Board Resignations SANTA MONICA, Calif. / Mar 14, 2024 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX), the leading destination for prescription savings in the U.S., today announced Interim CEO Scott Wagner has extended his commitment to the Company. In addition, Stephen LeSieur and Adam Karol have notified GoodRx of their decision to resign from the Company’s Board of Directors, effective March 14,... Read More

SANTA MONICA, Calif. / Feb 29, 2024 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings in the U.S., has released its financial results for the fourth quarter and full year 2023, which are consistent with its preliminary results announced on January 10, 2024. Fourth Quarter 2023 Highlights Revenue 1 and Adjusted Revenue 1,2 of $196.6 million Net... Read More

SANTA MONICA, Calif. / Feb 20, 2024 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings in the U.S., today announced that executives from the Company will participate in a fireside chat at each of the following investor conferences: TD Cowen 44th Annual Health Care Conference in Boston, MA on Tuesday, March 5, 2024 at 9:10 a.m. Eastern Time... Read More

SANTA MONICA, Calif. / Feb 01, 2024 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings in the U.S, today announced it will release its fourth quarter and full year 2023 financial results before U.S. markets open on Thursday, February 29, 2024. GoodRx management will also hold a conference call and webcast that morning at 5:00 a.m. Pacific Time... Read More

SANTA MONICA, Calif. / Jan 22, 2024 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings, today announced its intention to refinance its first lien credit facilities. The Company is seeking to refinance its first lien term loan facility and concurrently amend its revolving credit facility to extend the maturity date. The terms of the proposed... Read More

New report reveals that by improving medication access and adherence, GoodRx has helped save Americans $65 billion and the healthcare system over $5 billion SANTA MONICA, Calif. / Jan 11, 2024 / Business Wire / GoodRx (NASDAQ: GDRX), the leading destination for prescription savings, today shared a report looking at the company’s impact on social welfare as a result of helping millions of people access affordable medications.... Read More

Preliminary fourth quarter Revenue and Adjusted Revenue exceed previously announced guidance SANTA MONICA, Calif. / Jan 10, 2024 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings, today provided preliminary unaudited financial results for the fourth quarter and fiscal year ended December 31, 2023. Fourth Quarter 2023 Revenue 1,2 and Adjusted... Read More

Former Chief Financial Officer of The Honest Company brings over 25 years of experience across retail and consumer brands SANTA MONICA, Calif. / Dec 22, 2023 / Business Wire / GoodRx (Nasdaq: GDRX), a leading resource for healthcare savings and information, today announced the election of Kelly J. Kennedy to its Board of Directors. Kennedy will serve as a member of the Board’s audit committee and fill the seat left vacant by... Read More

SANTA MONICA, Calif. / Dec 13, 2023 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading resource for healthcare savings and information, today announced that executives from the Company will participate in a fireside chat at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 10, 2024 at 8:15 a.m. Pacific Time (11:15 a.m. Eastern Time). The live webcast will be available... Read More

SANTA MONICA, Calif. / Nov 16, 2023 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading resource for healthcare savings and information, today announced that executives from the Company will participate in a fireside chat at the Evercore ISI HealthCONx Conference in Miami, FL on Thursday, November 30, 2023 at 9:30 a.m. Pacific Time (12:30 p.m. Eastern Time). The live webcast will be available on the Company's... Read More

SANTA MONICA, Calif. / Nov 09, 2023 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), a leading resource for healthcare savings and information, has released its financial results for the third quarter 2023. Third Quarter 2023 Highlights Revenue 1 of $180.0 million Adjusted Revenue 1,2 of $190.0 million Net loss of $38.5 million; Net loss margin of 21.4% Adjusted Net Income 2 of $25.5... Read More

Integration allows people living with diabetes – with or without insurance – to access Sanofi’s most-prescribed insulin at a fixed rate anywhere GoodRx is accepted SANTA MONICA, Calif. / Oct 19, 2023 / Business Wire / GoodRx (NASDAQ: GDRX), a leading resource for healthcare savings and information, today announced it is working with Sanofi (NASDAQ: SNY), a global leader in diabetes care, to offer a new way for people living... Read More

SANTA MONICA, Calif. / Oct 12, 2023 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), a leading resource for healthcare savings and information, today announced it will release its third quarter 2023 financial results before U.S. markets open on Thursday, November 9, 2023. GoodRx management will also hold a conference call and webcast that morning at 5:00 a.m. Pacific Time (8:00 a.m. Eastern... Read More

Eligible Navitus members can now automatically access real-time comparative pricing at point of sale to improve affordability SANTA MONICA, Calif. / Oct 12, 2023 / Business Wire / GoodRx (NASDAQ: GDRX), a leading resource for healthcare savings and information, and Navitus Health Solutions, LLC , a pass-through pharmacy benefit manager (PBM) committed to removing cost from the drug supply chain, today announced the launch of... Read More

Company saved Americans more than $20 million on cold and flu treatments last season SANTA MONICA, Calif. / Sep 21, 2023 / Business Wire / GoodRx (NASDAQ: GDRX), a leading resource for healthcare savings and information, today announced it is offering new savings on antivirals, medications and vaccines for the upcoming cold and flu season . Last flu season (October 1, 2022 through April 30, 2023), the CDC estimates that... Read More

Companies team up at the pharmacy counter to drive medication adherence and better health outcomes SANTA MONICA, Calif. & SAN DIEGO / Sep 13, 2023 / Business Wire / GoodRx (NASDAQ: GDRX), a leading resource for healthcare savings and information, and MedImpact , the independent pharmacy benefit manager (PBM) and health solutions company, today announced a new savings solution designed to integrate GoodRx’s prescription... Read More

Lower prices offer added savings on top medications for heart disease, men’s health, mental health and more SANTA MONICA, Calif. / Sep 11, 2023 / Business Wire / GoodRx (NASDAQ: GDRX), a leading resource for healthcare savings and information, today announced a new initiative at Walgreens to reduce prices on nearly 200... Read More

SANTA MONICA, Calif. / Aug 30, 2023 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading resource for healthcare savings and information, today announced that executives from the Company will be presenting at the Morgan Stanley Global Healthcare Conference in New York, NY on Wednesday, September 13, 2023 at 6:30 a.m. Pacific Time (9:30 a.m. Eastern Time). A live webcast of the presentation will be available on... Read More

Developed with AssistRx, this new feature makes GoodRx the only platform for healthcare professionals to compare insurance prices, cash prices and manufacturer savings programs in one place SANTA MONICA, Calif. / Aug 30, 2023 / Business Wire / GoodRx (NASDAQ: GDRX), a leading resource for healthcare savings and information,... Read More

Second quarter financial results exceed previously announced guidance SANTA MONICA, Calif. / Aug 09, 2023 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), a leading resource for healthcare savings and information, has released its financial results for the second quarter 2023. Second Quarter 2023 Highlights Total revenue of $189.7 million, exceeding previously announced guidance Net income... Read More

Medicine Cabinet enables consumers to keep track of their medications, find the lowest prices, and earn rewards for staying on track SANTA MONICA, Calif. / Jul 27, 2023 / Business Wire / GoodRx (NASDAQ: GDRX), a leading resource for healthcare savings and information, today announced Medicine Cabinet , a comprehensive solution... Read More

SANTA MONICA, Calif. / Jul 12, 2023 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), a leading resource for healthcare savings and information, today announced it will release its second quarter 2023 financial results before U.S. markets open on Wednesday, August 9, 2023. GoodRx management will also hold a conference call and webcast that morning at 5:00 a.m. Pacific Time (8:00 a.m. Eastern... Read More

Gemmell to co-lead Pharma Manufacturer Solutions business, oversee GoodRx Health and Provider Mode SANTA MONICA, Calif. / Jul 10, 2023 / Business Wire / GoodRx (Nasdaq: GDRX), a leading resource for healthcare savings and information, today announced the appointment of Dorothy Gemmell as Chief Commercial Officer, effective July 3, 2023. Gemmell will work closely with Aaron Crittenden, newly appointed Chief Revenue Officer,... Read More

SANTA MONICA, Calif. / May 25, 2023 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading digital healthcare platform, today announced that executives from the Company will be presenting at the Jefferies Healthcare Conference in New York, NY on Thursday, June 8, 2023 at 12:30 p.m. Pacific Time (3:30 p.m. Eastern Time). A live webcast of the presentation will be available on the Company's Investor Relations... Read More

First quarter financial results exceed previously announced guidance SANTA MONICA, Calif. / May 10, 2023 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), a leading digital healthcare platform, has released its financial results for the first quarter 2023. First Quarter 2023 Highlights Total revenue of $184.0 million, exceeding previously announced guidance Net loss of $3.3 million 1 ; Net... Read More

SANTA MONICA, Calif. / Apr 27, 2023 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading digital healthcare platform, today announced that executives from the Company will be presenting at the BofA Securities 2023 Health Care Conference in Las Vegas, NV, on Thursday, May 11, 2023 at 9:20 a.m. Pacific Time (12:20 p.m. Eastern Time). A live webcast of the presentation will be available on the Company's Investor... Read More

Scott Wagner, Former CEO of GoDaddy, Appointed Interim CEO GoodRx Co-Founders Doug Hirsch and Trevor Bezdek to Serve as Chief Mission Officer and Chairman, Respectively SANTA MONICA, Calif. / Apr 25, 2023 / Business Wire / GoodRx Holdings, Inc. (NASDAQ: GDRX), a leading digital healthcare platform, today announced that Scott... Read More

SANTA MONICA, Calif. / Apr 12, 2023 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), a leading digital healthcare platform, today announced it will release its first quarter 2023 financial results before U.S. markets open on Wednesday, May 10, 2023. GoodRx management will also hold a conference call and webcast that morning at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the... Read More

SANTA MONICA, Calif. / Feb 28, 2023 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading digital healthcare platform, has released its financial results for the fourth quarter and full year 2022. Fourth Quarter 2022 Highlights Total revenue of $184.1 million, exceeding previously announced guidance Net loss of $2.0 1 million; Net loss margin of 1.1% Adjusted Net Income 2 of $27.4 million; Adjusted Net Income... Read More

SANTA MONICA, Calif. / Jan 31, 2023 / Business Wire / GoodRx Holdings Inc. (Nasdaq: GDRX), a leading digital healthcare platform, today announced it will release its fourth quarter and full year 2022 financial results after U.S. markets close on Tuesday, February 28, 2023. GoodRx management will also hold a conference call and webcast that day at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss the results and the... Read More

GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced that executives from the Company will be presenting at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 11, 2023 at 3:45 p.m. Pacific Time (6:45 p.m. Eastern Time). A live webcast of the presentation will be available on the Company's Investor Relations website,... Read More